Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Minoxidil for Recurrent Platinum Resistant Ovarian Cancer
NCT05272462Phase 2Unknown
- Sponsor
- Loyola University Chicago
- Start
- Dec 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of minoxidil in ovarian cancer, sponsored by Loyola University Chicago. Primary endpoint: Overall Response Rate. Status: unknown.
02
Drugs
minoxidil
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT05272462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05272462.